Literature DB >> 22591369

Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism.

Lindsay Festa1, Olimpia Meucci.   

Abstract

Human immunodeficiency virus 1 (HIV-1) and its associated proteins can have a profound impact on the central nervous system. Co-morbid abuse of opiates, such as morphine and heroin, is often associated with rapid disease progression and greater neurological dysfunction. The mechanisms by which HIV proteins and opiates cause neuronal damage on their own and together are unclear. The emergence of ferritin heavy chain (FHC) as a negative regulator of the chemokine receptor CXCR4, a co-receptor for HIV, may prove to be important in elucidating the interaction between HIV proteins and opiates. This review summarizes our current knowledge of central nervous system damage inflicted by HIV and opiates, as well as the regulation of CXCR4 by opiate-induced changes in FHC protein levels. We propose that HIV proteins and opiates exhibit an additive or synergistic effect on FHC/CXCR4, thereby decreasing neuronal signaling and function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22591369      PMCID: PMC3987816          DOI: 10.2174/157016212802138751

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  133 in total

Review 1.  Dendritic spines, synaptic plasticity and neuronal survival: activity shapes dendritic spines to enhance neuronal viability.

Authors:  Menahem Segal
Journal:  Eur J Neurosci       Date:  2010-06-09       Impact factor: 3.386

2.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.

Authors:  H W Matthes; R Maldonado; F Simonin; O Valverde; S Slowe; I Kitchen; K Befort; A Dierich; M Le Meur; P Dollé; E Tzavara; J Hanoune; B P Roques; B L Kieffer
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

3.  Cerebrospinal fluid ferritin in HIV infected patients with acute neurological episodes.

Authors:  F Deisenhammer; R F Miller; N S Brink; M J Harrison; E J Thompson
Journal:  Genitourin Med       Date:  1997-06

Review 4.  Disruption of neuronal CXCR4 function by opioids: preliminary evidence of ferritin heavy chain as a potential etiological agent in neuroAIDS.

Authors:  Jonathan Pitcher; Saori Shimizu; Silvia Burbassi; Olimpia Meucci
Journal:  J Neuroimmunol       Date:  2010-06-08       Impact factor: 3.478

Review 5.  Could a dysfunction of ferritin be a determinant factor in the aetiology of some neurodegenerative diseases?

Authors:  Carmen Quintana; Lucía Gutiérrez
Journal:  Biochim Biophys Acta       Date:  2010-05-03

6.  CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons.

Authors:  J Hesselgesser; M Halks-Miller; V DelVecchio; S C Peiper; J Hoxie; D L Kolson; D Taub; R Horuk
Journal:  Curr Biol       Date:  1997-02-01       Impact factor: 10.834

7.  Expression of HIV regulatory and structural mRNA in the central nervous system.

Authors:  C A Wiley; M Baldwin; C L Achim
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

Review 8.  Human immunodeficiency virus and the brain.

Authors:  J D Glass; R T Johnson
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

9.  Morphine enhances Tat-induced activation in murine microglia.

Authors:  Sirosh M Bokhari; Honghong Yao; Crystal Bethel-Brown; Peng Fuwang; Rachel Williams; Navneet K Dhillon; Ramakrishna Hegde; Anil Kumar; Shilpa J Buch
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

Review 10.  HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.

Authors:  Kathryn A Lindl; David R Marks; Dennis L Kolson; Kelly L Jordan-Sciutto
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-16       Impact factor: 4.147

View more
  8 in total

Review 1.  Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders.

Authors:  Bradley Nash; Lindsay Festa; Chihyang Lin; Olimpia Meucci
Journal:  Brain Res       Date:  2019-08-26       Impact factor: 3.252

Review 2.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

Review 3.  Functions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-opioid receptors.

Authors:  Bradley Nash; Olimpia Meucci
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

4.  The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis.

Authors:  Roman Shrestha; Damian Weikum; Michael Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2017-04

Review 5.  Co-receptor signaling in the pathogenesis of neuroHIV.

Authors:  E A Nickoloff-Bybel; L Festa; O Meucci; P J Gaskill
Journal:  Retrovirology       Date:  2021-08-24       Impact factor: 4.602

6.  Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans.

Authors:  Mehran Rahimi; Manlio Vinciguerra; Mojtaba Daghighi; Behiye Özcan; Vishtaseb Akbarkhanzadeh; Fareeba Sheedfar; Marzyeh Amini; Tommaso Mazza; Valerio Pazienza; Mahdi M Motazacker; Morteza Mahmoudi; Felix W M De Rooij; Eric Sijbrands; Maikel P Peppelenbosch; Farhad Rezaee
Journal:  Oncotarget       Date:  2015-10-06

7.  ASPP2 involvement in p53-mediated HIV-1 envelope glycoprotein gp120 neurotoxicity in mice cerebrocortical neurons.

Authors:  Zhiying Liu; Yunjin Zang; Luxin Qiao; Kai Liu; Yabo Ouyang; Yulin Zhang; Dexi Chen
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

Review 8.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.